14-34711940-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_138638.5(CFL2):c.*925T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.205 in 454,002 control chromosomes in the GnomAD database, including 11,912 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.25 ( 5973 hom., cov: 33)
Exomes 𝑓: 0.18 ( 5939 hom. )
Consequence
CFL2
NM_138638.5 3_prime_UTR
NM_138638.5 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.241
Genes affected
CFL2 (HGNC:1875): (cofilin 2) This gene encodes an intracellular protein that is involved in the regulation of actin-filament dynamics. This protein is a major component of intranuclear and cytoplasmic actin rods. It can bind G- and F-actin in a 1:1 ratio of cofilin to actin, and it reversibly controls actin polymerization and depolymerization in a pH-dependent manner. Mutations in this gene cause nemaline myopathy type 7, a form of congenital myopathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 14-34711940-A-G is Benign according to our data. Variant chr14-34711940-A-G is described in ClinVar as [Benign]. Clinvar id is 313088.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.452 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFL2 | NM_138638.5 | c.*925T>C | 3_prime_UTR_variant | 4/4 | ENST00000298159.11 | NP_619579.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CFL2 | ENST00000298159.11 | c.*925T>C | 3_prime_UTR_variant | 4/4 | 1 | NM_138638.5 | ENSP00000298159 | P1 | ||
CFL2 | ENST00000341223.8 | c.*925T>C | 3_prime_UTR_variant | 4/4 | 1 | ENSP00000340635 | P1 | |||
CFL2 | ENST00000672517.1 | c.*925T>C | 3_prime_UTR_variant | 5/5 | ENSP00000500532 | P1 |
Frequencies
GnomAD3 genomes AF: 0.246 AC: 37341AN: 151992Hom.: 5968 Cov.: 33
GnomAD3 genomes
AF:
AC:
37341
AN:
151992
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.191 AC: 26009AN: 136410Hom.: 2966 AF XY: 0.194 AC XY: 14370AN XY: 74072
GnomAD3 exomes
AF:
AC:
26009
AN:
136410
Hom.:
AF XY:
AC XY:
14370
AN XY:
74072
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.184 AC: 55527AN: 301892Hom.: 5939 Cov.: 0 AF XY: 0.191 AC XY: 32847AN XY: 172042
GnomAD4 exome
AF:
AC:
55527
AN:
301892
Hom.:
Cov.:
0
AF XY:
AC XY:
32847
AN XY:
172042
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.246 AC: 37385AN: 152110Hom.: 5973 Cov.: 33 AF XY: 0.243 AC XY: 18084AN XY: 74352
GnomAD4 genome
AF:
AC:
37385
AN:
152110
Hom.:
Cov.:
33
AF XY:
AC XY:
18084
AN XY:
74352
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
836
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Nemaline myopathy 7 Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at